Institute for Progress — August 2022 Update
Hello!
Hope you all have been enjoying the last few weeks of summer. Here’s what the IFP team has been up to recently:
✍️ Published Work
Caleb and Heidi wrote an op-ed in the Washington Post that proposed three ideas for boosting biomedical innovation in the wake of Medicare prescription drug price changes
Alec and Jeremy wrote an article for Noah Smith’s newsletter making the case for high-skilled immigration reform (and offered politically tractable ideas for where to start)
Adin wrote a comprehensive analysis of how to maintain food supplies in future pandemics
Heidi shared the presentations from the NBER Innovation Research Boot Camp for PhD students that she co-hosted with Kevin Bryan and Ben Jones
🎤 Interviews & Events
Matt was interviewed by James Pethokoukis in his Faster, Please newsletter
Caleb went on the Narratives podcast
Alec went on the McKinsey Global Institute’s Forward Thinking podcast
📰 Media
Jeremy’s work on the semiconductor workforce was quoted in Reason
“Solving those delays is all the more critical given the clear present need for foreign workers. ‘Even with significant recruitment from other industries and from academia, thousands of new jobs will remain vacant unless the industry is empowered to recruit top talent from abroad,’ notes Jeremy Neufeld of the Institute for Progress.”
Jeremy spoke to National Journal about the politics behind immigration getting left out of the CHIPS and Science Act
Jeremy also spoke to Voice of America
☀️ New Things Under the Sun by IFP Senior Innovation Economist Matt Clancy
🏗️ Construction Physics by IFP Senior Fellow Brian Potter
Why are there so few economies of scale in construction? Part I
Why aren't there economies of scale in building size? Part III
👀 Progress Is Possible in DC (what we’re watching)
The Administration for Strategic Preparedness and Response (ASPR) was reclassified from a staff division to an operating division, which means it has equal status to the other operating divisions of HHS such as CDC and FDA
After a mixed COVID-19 response from the Centers for Disease Control and Prevention, CDC Director Rochelle Walensky announced a reorganization aimed at making the agency less academic and more operational in addressing future public health crises
Walensky: “To be frank, we are responsible for some pretty dramatic, pretty public mistakes, from testing to data to communications.”
👋 Tweet for the Road
